Biotricity (NASDAQ:BTCY – Get Free Report) will likely be releasing its earnings data on Tuesday, February 18th. Analysts expect Biotricity to post earnings of ($0.11) per share for the quarter.
Biotricity Price Performance
Shares of NASDAQ BTCY opened at $0.39 on Tuesday. Biotricity has a one year low of $0.19 and a one year high of $1.67. The business’s 50-day moving average price is $0.34 and its two-hundred day moving average price is $0.37. The company has a market capitalization of $9.58 million, a P/E ratio of -0.28 and a beta of 1.18.
Analyst Upgrades and Downgrades
Separately, HC Wainwright reissued a “neutral” rating on shares of Biotricity in a research note on Monday, November 18th.
About Biotricity
Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.
Featured Articles
- Five stocks we like better than Biotricity
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- 5 discounted opportunities for dividend growth investors
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.
